» Articles » PMID: 22990206

Neuropsychological and Neuroimaging Markers in Early Versus Late-onset Alzheimer's Disease

Overview
Publisher Sage Publications
Specialty Neurology
Date 2012 Sep 20
PMID 22990206
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Early-onset Alzheimer's disease (EOAD) has been overshadowed by the more common late-onset AD (LOAD). Yet, the literature indicates EOAD may have less hippocampal-memory presentations and more focal neocortical localization early in the disease.

Objective: To evaluate these proposed differences between these 2 forms of AD and to explore what they inform about differences in AD pathophysiology.

Methods: In all, 21 patients with EOAD and 24 patients with LOAD matched for disease progression and severity were compared on neurocognitive measures and resting state fluorodeoxy-glucose positron-emission tomography (FDG-PET).

Results: Patients with EOAD had worse executive functions with greater hypometabolism in the parietal regions; whereas patients with LOAD had worse confrontation naming and verbal recognition memory with greater hypometabolism in inferior frontotemporal regions.

Conclusions: In addition to highlighting significant differences between EOAD and LOAD, these results reveal dissociation between executive deficits in AD and frontal hypometabolism, suggesting early disturbances of the parietal-frontal network in EOAD.

Citing Articles

Clinical characteristics and biomarker profile in early- and late-onset Alzheimer's disease: the Shanghai Memory Study.

Wu J, Wang J, Xiao Z, Lu J, Ma X, Zhou X Brain Commun. 2025; 7(1):fcaf015.

PMID: 39850631 PMC: 11756380. DOI: 10.1093/braincomms/fcaf015.


Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer's disease.

Iaccarino L, Llibre-Guerra J, McDade E, Edwards L, Gordon B, Benzinger T Brain Commun. 2024; 6(3):fcae159.

PMID: 38784820 PMC: 11114609. DOI: 10.1093/braincomms/fcae159.


Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer's disease.

Llibre-Guerra J, Iaccarino L, Coble D, Edwards L, Li Y, McDade E Brain Commun. 2023; 5(6):fcad280.

PMID: 37942088 PMC: 10629466. DOI: 10.1093/braincomms/fcad280.


The APOE4 effect: structural brain differences in Alzheimer's disease according to the age at symptom onset.

Forno G, Contador J, Perez-Millan A, Guillen N, Falgas N, Sarto J Eur J Neurol. 2022; 30(3):597-605.

PMID: 36463489 PMC: 10108138. DOI: 10.1111/ene.15657.


Clinical Manifestations of Early-Onset Dementia With Lewy Bodies Compared With Late-Onset Dementia With Lewy Bodies and Early-Onset Alzheimer Disease.

Sim J, Li H, Hameed S, Ting S JAMA Neurol. 2022; 79(7):702-709.

PMID: 35604656 PMC: 9127709. DOI: 10.1001/jamaneurol.2022.1133.


References
1.
Hamacher K, Coenen H, Stocklin G . Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med. 1986; 27(2):235-8. View

2.
Kim E, Cho S, Jeong Y, Park K, Kang S, Kang E . Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients. Brain. 2005; 128(Pt 8):1790-801. DOI: 10.1093/brain/awh539. View

3.
Filley C, Kelly J, Heaton R . Neuropsychologic features of early- and late-onset Alzheimer's disease. Arch Neurol. 1986; 43(6):574-6. DOI: 10.1001/archneur.1986.00520060038014. View

4.
Jacobs D, Sano M, Marder K, Bell K, Bylsma F, LaFleche G . Age at onset of Alzheimer's disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology. 1994; 44(7):1215-20. DOI: 10.1212/wnl.44.7.1215. View

5.
Tombaugh T . Trail Making Test A and B: normative data stratified by age and education. Arch Clin Neuropsychol. 2004; 19(2):203-14. DOI: 10.1016/S0887-6177(03)00039-8. View